submitted on 2023-03-15, 08:01 and posted on 2023-03-16, 06:19authored byMohamad Y. Khatib, Amna A. Ahmed, Said B. Shaat, Ahmed S. Mohamed, Abdulqadir J. Nashwan
The authors urge clinicians to balance the use of Immunosuppressant drugs and tocilizumab for COVID-19 patients to avoid the development of infections like Cryptococcemia, leading to death within 30 days.